Close
Smartlab Europe
Achema middle east

Covid Vaccine: India Orders Over 6 Crore Doses From SII, Bharat Biotech

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug

Teva Pharmaceutical Industries and Royalty Pharma have signed a...

Pierre Fabre, Iktos Launch AI-Driven Oncology Drug Discovery

An integrated partnership has been formed between Pierre Fabre...

Revvity and Lilly Expand Lilly TuneLab Access via Signals

Revvity, Inc. announced a collaboration with Eli Lilly and...
- Advertisement -

The government has placed orders in advanced commitments for over 6 crore doses of Covid-19 vaccine from Serum Institute of India (SII) and Bharat Biotech for inoculating 3 crore healthcare and frontline workers in the first phase of the vaccination drive.

The vaccination drive is scheduled to start from January 16 and will cost Rs 1,300 crore.

According to sources, the government placed a purchase order with the Serum Institute for 1.1 crore doses of Oxford Covid-19 vaccine, Covishield, each costing Rs 210, including the GST.

The government is committed to buying 4.5 crore more by April, sources told news agency PTI. The government has also placed an order to Bharat Biotech for 55 lakh doses of Covaxin, costing Rs 162 crore.

According to the order placed, each dose of Covishield has been priced at Rs 200 and with GST of Rs 10, it would cost Rs 210. The HLL Lifecare Limited, a public sector undertaking, issued the supply order on behalf of the Union Health Ministry.

The first order of 1.1 crore doses will be worth Rs 231 crore, while the total amount, including the commitment for 4.5 crore doses, with the total estimated to reach Rs 1,176 crore at current rates, they said.

The first consignment of Covishield vaccines left the Serum Institute of India in the wee hours on Tuesday ahead of the January 16 nationwide inoculation drive launch.

Latest stories

Related stories

Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug

Teva Pharmaceutical Industries and Royalty Pharma have signed a...

Pierre Fabre, Iktos Launch AI-Driven Oncology Drug Discovery

An integrated partnership has been formed between Pierre Fabre...

Revvity and Lilly Expand Lilly TuneLab Access via Signals

Revvity, Inc. announced a collaboration with Eli Lilly and...

The Role of Therapy in Managing Chronic Stress and Trauma

Have you ever felt like you’re constantly tired, even...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »